WEBINAR DETAILS
  • About
    Medigene will host an R&D Event on its optimal 3S (specific, sensitive, and safe) TCRs for TCR-guided precision immunotherapies including its lead program MDG1015.
  • Duration
    1 hour
  • Price
    Free
  • Language
    English
  • OPEN TO
    Everyone
  • Dial-in Number
    Please register for this Webinar to view the dial-in info.
FEATURED PRESENTERS
  • Webinar hosting presenter

    Dr Selwyn Ho

    CEO at Medigene
    Dr Selwyn Ho is a seasoned healthcare executive, with over 25 years of international experience spanning Europe, the US and Asia. He has held senior leadership roles in both private and publicly traded biotech and pharmaceutical companies, with a...
    Full Profile
  • Webinar hosting presenter

    Prof Dolores Schendel

    CSO at Medigene
    Professor Dolores Schendel is a leading expert in T cell research and immunotherapy, with decades of experience and nearly 200 scientific publications. She has served on the scientific review boards of prestigious organisations, including the...
    Full Profile
  • Webinar hosting presenter

    Dr Kirsty Crame

    VP Clinical Development at Medigene
    Dr Kristy Crame is a Doctor of Medicine, with over 10 years of experience in the biotech industry, including six years specialising in cell therapy. Currently the vice president of clinical research and development at Medigene, Dr Crame has held...
    Full Profile
  • Webinar hosting presenter

    Dr Barbara Loesch

    Head of Technology & Innovation Department at Medigene
    Dr Barbara Loesch, a trained biologist, brings over 18 years of experience in adoptive immune cell therapy (Immunis). She joined Medigene Immunotherapies in 2018 and currently serves as the head of the technology and innovation department. Dr...
    Full Profile
  • Webinar hosting presenter

    Dr David Zhen

    Principal Investigator at Medigene
    Dr David Zhen is an associate professor of medicine at Fred Hutchinson Cancer Center and the University of Washington, and co-director of the neuroendocrine tumour programme. Dr Zhen’s research focuses on developing new therapies for...
    Full Profile
HOSTED BY
Powered by BigMarker